Sironen R - Search Results

1

The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma.

Salmi S, Siiskonen H, Sironen R, Tyynelä-Korhonen K, Hirschovits-Gerz B, Valkonen M, Auvinen P, Pasonen-Seppänen S. Salmi S, et al. Among authors: sironen r. Melanoma Res. 2019 Jun;29(3):237-247. doi: 10.1097/CMR.0000000000000522. Melanoma Res. 2019. PMID: 30399061 Free PMC article.

2

Hyaluronan in human malignancies.

Sironen RK, Tammi M, Tammi R, Auvinen PK, Anttila M, Kosma VM. Sironen RK, et al. Exp Cell Res. 2011 Feb 15;317(4):383-91. doi: 10.1016/j.yexcr.2010.11.017. Epub 2010 Dec 3. Exp Cell Res. 2011. PMID: 21134368 Review.

3

Transcription factors zeb1, twist and snai1 in breast carcinoma.

Soini Y, Tuhkanen H, Sironen R, Virtanen I, Kataja V, Auvinen P, Mannermaa A, Kosma VM. Soini Y, et al. Among authors: sironen r. BMC Cancer. 2011 Feb 16;11:73. doi: 10.1186/1471-2407-11-73. BMC Cancer. 2011. PMID: 21324165 Free PMC article.

4

Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancer.

Auvinen P, Tammi R, Kosma VM, Sironen R, Soini Y, Mannermaa A, Tumelius R, Uljas E, Tammi M. Auvinen P, et al. Among authors: sironen r. Int J Cancer. 2013 Feb 1;132(3):531-9. doi: 10.1002/ijc.27707. Epub 2012 Jul 20. Int J Cancer. 2013. PMID: 22753277 Free article.

5

Inverse expression of hyaluronidase 2 and hyaluronan synthases 1-3 is associated with reduced hyaluronan content in malignant cutaneous melanoma.

Siiskonen H, Poukka M, Tyynelä-Korhonen K, Sironen R, Pasonen-Seppänen S. Siiskonen H, et al. Among authors: sironen r. BMC Cancer. 2013 Apr 5;13:181. doi: 10.1186/1471-2407-13-181. BMC Cancer. 2013. PMID: 23560496 Free PMC article.

6

Hyaluronan synthases (HAS1-3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival.

Auvinen P, Rilla K, Tumelius R, Tammi M, Sironen R, Soini Y, Kosma VM, Mannermaa A, Viikari J, Tammi R. Auvinen P, et al. Among authors: sironen r. Breast Cancer Res Treat. 2014 Jan;143(2):277-86. doi: 10.1007/s10549-013-2804-7. Epub 2013 Dec 14. Breast Cancer Res Treat. 2014. PMID: 24337597

7

Decreased hyaluronidase 1 expression is associated with early disease recurrence in human endometrial cancer.

Nykopp TK, Pasonen-Seppänen S, Tammi MI, Tammi RH, Kosma VM, Anttila M, Sironen R. Nykopp TK, et al. Among authors: sironen r. Gynecol Oncol. 2015 Apr;137(1):152-9. doi: 10.1016/j.ygyno.2015.01.525. Epub 2015 Jan 10. Gynecol Oncol. 2015. PMID: 25584766

8

Low numbers of tryptase+ and chymase+ mast cells associated with reduced survival and advanced tumor stage in melanoma.

Siiskonen H, Poukka M, Bykachev A, Tyynelä-Korhonen K, Sironen R, Pasonen-Seppänen S, Harvima IT. Siiskonen H, et al. Among authors: sironen r. Melanoma Res. 2015 Dec;25(6):479-85. doi: 10.1097/CMR.0000000000000192. Melanoma Res. 2015. PMID: 26317168

9

Decreased expression of hyaluronan synthase 1 and 2 associates with poor prognosis in cutaneous melanoma.

Poukka M, Bykachev A, Siiskonen H, Tyynelä-Korhonen K, Auvinen P, Pasonen-Seppänen S, Sironen R. Poukka M, et al. Among authors: sironen r. BMC Cancer. 2016 May 16;16:313. doi: 10.1186/s12885-016-2344-8. BMC Cancer. 2016. PMID: 27184066 Free PMC article.

10

Cellular hyaluronan is associated with a poor prognosis in renal cell carcinoma.

Jokelainen O, Pasonen-Seppänen S, Tammi M, Mannermaa A, Aaltomaa S, Sironen R, Nykopp TK. Jokelainen O, et al. Among authors: sironen r. Urol Oncol. 2020 Aug;38(8):686.e11-686.e22. doi: 10.1016/j.urolonc.2020.03.029. Epub 2020 Apr 30. Urol Oncol. 2020. PMID: 32360171

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

69 results

Search Page